Quadrivalent Influenza Vaccine（Split Virion）(MDCK cell)(Xinnoming Biotechnology)

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameQuadrivalent Influenza Vaccine（Split Virion）(MDCK cell)(Xinnoming Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLanzhou Bailing Biotechnology Co LtdChengdu Xinnoming Biotechnology Co LtdChengdu Oulin Biological Science & Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Oulin Biological Science & Technology Co LtdLanzhou Bailing Biotechnology Co LtdChengdu Xinnoming Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A